image
Adicet Bio, Inc. ACET
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.9469
-9.82 %
$ 78 M
Market Cap
-0.56
P/E
BALANCE SHEET
207 M ASSETS
-37.31%
Growth Rates
1Year -37.31%
3Years 10.45%
5Years 13.52%
7Years -12.80%
10Years -4.35%
37.1 M LIABILITIES
-3.21%
Growth Rates
1Year -3.21%
3Years -5.52%
5Years 45.28%
7Years -23.24%
10Years -11.70%
170 M EQUITY
171.47%
Growth Rates
1Year 171.47%
3Years 53.27%
5Years 10.31%
7Years -7.97%
10Years -1.33%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Adicet Bio, Inc.
image
Current Assets 162 M
Cash & Short-Term Investments 160 M
Receivables 0
Other Current Assets 2.56 M
Non-Current Assets 45 M
Long-Term Investments 0
PP&E 44.2 M
Other Non-Current Assets 822 K
Current Liabilities 19.3 M
Accounts Payable 2.62 M
Short-Term Debt 6.44 M
Other Current Liabilities 10.2 M
Non-Current Liabilities 17.8 M
Long-Term Debt 17.7 M
Other Non-Current Liabilities 130 K

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Jun-2017 Jun-2016 Jun-2015 Jun-2014 Jun-2013 Jun-2012 Jun-2011 Jun-2010 Jun-2009 Jun-2008
ASSETS
Cash & Cash Equivalents 159.7 257.7 277.5 84.3 10.6 7.0 53.3 66.8 34.0 42.9 33.2 24.9 28.7 30.9 57.8 46.5
Short Term Investments 0 0 0 10.3 51.8 101.0 2.0 0.9 3.4 0.7 2.1 1.5 0.9 0.3 0.5 0.5
Receivables 0 0.4 0.2 0 0.9 0 0 167.6 161.5 122.7 90.1 74.7 83.7 74.7 0 0
Inventory 0 2.6 4.7 (3.1) 0.7 0 136.4 98.1 95.6 100.7 83.8 84.7 77.4 74.9 54.4 71.1
Other Current Assets 2.6 2.9 4.7 5.6 0.9 0.9 0.9 19.2 15.8 9.3 9.0 6.2 7.8 14.8 58.9 75.6
Total Current Assets 162.3 261.0 282.4 94.6 64.2 109.5 54.2 352.7 310.3 276.4 218.3 192.0 198.6 195.6 171.6 193.8
PP&E 44.2 49.0 35.0 25.9 2.1 0.3 39 K 10.0 10.5 11.6 11.4 11.7 12.1 6.9 4.2 4.3
Intangible Assets 0 0 0 1.2 0 0 285.1 79.1 79.0 88.0 40.8 45.3 50.7 12.4 11.5 5.4
Goodwill 0 19.5 19.5 20.1 0 0 237.0 67.9 67.9 66.5 33.5 33.5 33.6 1.7 1.9 2.0
Long Term Investments 0 0 0.1 4.5 10.6 84 K (541.5) 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0.8 1.2 2.0 12.1 4.7 1 0.9 13.1 12.2 14.0 11.3 12.1 0 0 0 0
Other Assets 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0
Total Assets 207.3 330.7 338.9 153.8 81.6 109.9 55.2 540.8 489.8 468.0 323.4 299.3 295.0 216.6 189.3 205.5
LIABILITIES
Accounts Payable 2.6 4.4 3.3 1.6 1.1 0.5 1.5 46.0 55.0 48.7 39.2 42.0 44.6 40.0 25.1 43.5
Short Term Debt 6.4 5.0 3.1 2.4 0 0 14.5 0.2 10.2 8.3 11.7 6.7 0 0 0 0
Other Current Liabilities 10.2 10.3 5.1 4.5 2.8 5.2 (10.8) 47.3 57.8 54.6 34.3 24.1 37.8 32.8 20.2 19.8
Total Current Liabilities 19.3 19.7 16.3 14.0 14.9 5.7 5.5 98.9 125.0 118.5 89.9 73.6 83.2 74.6 46.9 65.0
Long Term Debt 17.7 18.5 19.4 20.4 0 3.1 339.2 118.6 100.0 97.2 20.4 39.1 6.2 33.6 20.7 19.9
Deferred Tax Income 0 0 0 0.1 (114.1) 0 7.3 9.1 66 K 6 K 6 K 8 K 0 0 0 0
Other Liabilities 0.1 0.1 0.1 1.0 116.2 (3.1) (346.5) 6.3 7.5 11.6 13.4 12.9 0 0 0 0
Total Liabilities 37.1 38.4 35.8 44.0 142.0 5.7 5.5 236.3 235.6 234.4 128.8 131.3 150.8 92.2 63.9 81.8
EQUITY
Common Stock 4 K 4 K 4 K 2 K 4 K 3 K 1 K 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3
Retained Earnings (380.8) (238.1) (168.3) (106.3) (69.6) (71.4) (33.8) 194.8 167.2 140.8 118.6 102.3 90.7 87.0 85.5 81.8
Other Accumulative Comprehensive Income/Loss 0 0 (338.9) 24 K 23 K 41 K (5.1) (6.3) (7.1) 5.4 2.9 1.3 7.7 1.0 7.5 13.1
Total Equity 170.2 (238.1) (168.3) (106.3) (60.4) 104.2 49.7 304.4 254.2 233.6 194.6 168.0 160.8 139.6 141.6 140.4
Total Liabilities and Equity 207.3 (199.8) (132.5) 153.8 81.6 109.9 55.2 540.8 489.8 468.0 323.4 299.3 295.0 216.6 189.3 205.5
SHARES OUTSTANDING
Common Shares Outstanding 43.0 41.1 31.0 7.3 18.6 29.8 26.8 28.0 24.5 23.7 23.7 23.3 22.7 21.9 21.4 21.3